He Ru Fen - Net Worth and Insider Trading

He Ru Fen Net Worth

The estimated net worth of He Ru Fen is at least $0 dollars as of 2024-09-23. He Ru Fen is the Supervisors of Huadong Medicine Co Ltd and owns about 0 shares of Huadong Medicine Co Ltd (SZSE:000963) stock worth over $0. Details can be seen in He Ru Fen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that He Ru Fen has not made any transactions after 2020-02-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of He Ru Fen

He Ru Fen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, He Ru Fen owns 1 companies in total, including Huadong Medicine Co Ltd (SZSE:000963) .

Click here to see the complete history of He Ru Fen’s form 4 insider trades.

Insider Ownership Summary of He Ru Fen

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:000963	Huadong Medicine Co Ltd	2020-02-24	Supervisors

He Ru Fen Latest Holdings Summary

He Ru Fen currently owns a total of 1 stock. He Ru Fen owns 0 shares of Huadong Medicine Co Ltd (SZSE:000963) as of February 24, 2020, with a value of $0.

Latest Holdings of He Ru Fen

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:000963	Huadong Medicine Co Ltd	2020-02-24	0	28.08	0

Holding Weightings of He Ru Fen

He Ru Fen Form 4 Trading Tracker

According to the SEC Form 4 filings, He Ru Fen has made a total of 1 transactions in Huadong Medicine Co Ltd (SZSE:000963) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Huadong Medicine Co Ltd is the sale of 6,000 shares on February 24, 2020, which brought He Ru Fen around $124,560.

Insider Trading History of He Ru Fen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

He Ru Fen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

He Ru Fen Ownership Network

Ownership Network List of He Ru Fen

No Data

Ownership Network Relation of He Ru Fen

He Ru Fen Owned Company Details

What does Huadong Medicine Co Ltd do?

Who are the key executives at Huadong Medicine Co Ltd?

He Ru Fen is the Supervisors of Huadong Medicine Co Ltd. Other key executives at Huadong Medicine Co Ltd include Supervisors Hu Bao Zhen , Executives Zhou Shun Hua , and Supervisors Shao Ling Min .

Huadong Medicine Co Ltd (SZSE:000963) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Huadong Medicine Co Ltd (SZSE:000963) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Huadong Medicine Co Ltd (SZSE:000963) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Huadong Medicine Co Ltd (SZSE:000963)'s detailed insider trading history can be found in Insider Trading Tracker table.

Huadong Medicine Co Ltd Insider Transactions

No Available Data

He Ru Fen Mailing Address

Above is the net worth, insider trading, and ownership report for He Ru Fen. Currently GuruFocus does not have mailing address information for He Ru Fen.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.